Study supports genetic testing for colorectal cancer: 4 key notes
A study conducted at Boston-based Dana-Farber Cancer Institute examined the role of genetic testing for inherited risk of colorectal cancer, Targeted Oncology reports.
Here's what you should know:
1. Researchers analyzed 1,058 individuals with colon cancer.
2. The patients agreed to have blood drawn for research.
3. Researchers performed germline testing on all individuals using a 25-gene panel to look for inherited mutations associated with cancer risk.
4. Researchers found that inherited mutations were identified in nearly 10 percent of individuals analyzed with the 25-gene panel.
Researchers said that number "was higher than what we would have expected in the past."
The researchers concluded that there might be a link between mutations in those genes and CRC risk.
More articles on gastroenterology:
Bowel cancer mortality rates drop 30% — 4 study insights
GI leader to know: Dr. Louis Leite of Pennsylvania Gastroenterology
2 new GI-driven ASCs & facilities — March 2017
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- Non-Medicaid expansion states could gain up to $27.9B in savings by expanding program: 4 takeaways
- Senate committee advances vote on Trump's FDA pick Dr. Scott Gottlieb
- GI leader to know: Dr. Michael Sagatelian of Palmetto Digestive Health Specialists
- Drs. Todd Baron & Kevin Collier: 2 GI physicians in the headlines
- New Century Spine and Outpatient Surgical Institute installs Indigo-Clean disinfecting lights